Amgen asks FDA for approval of key asthma drug

Amgen on Monday said it has submitted for Food and Drug Administration approval its asthma drug hopeful tezepelumab, advancing a medicine that's crucially important to its plans for growing beyond the aging blockbusters that have sustained its business for years.